SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
577F-10 $150m shelf registration sec.gov LAVAL, QC, Jan. 29, 2019 /PRNewswire/ - Sultan-2/13/2019
576Translated from french article courrierlaval.com Cannabis oil: Neptune obtaiSultan-2/3/2019
575Neptune’s CEO Jim Hamilton talks about the new license and the future of cannabiSultan-1/15/2019
574Out of the sea and into the factory for Acasti’s heart drug ingredient cen.acs.Sultan-1/12/2019
573Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by tSultan-1/9/2019
572Neptune Receives License to Process Cannabis from Health Canada finance.yahoo.Sultan-1/7/2019
571Yea!E_K_S-1/5/2019
570Neptune finally got their processing license today via subsidiary 9354-7537 QuebSultan-1/4/2019
569What is Chen Buying? What is Chen Selling? More from Chen - 11/16/18 - BiotSultan-1/2/2019
568Acasti Pharma Announces TRILOGY Phase 3 Trials of CaPre® in Patients with SSultan-12/31/2018
567ALIGN RESEARCH TOP 10 PICKS FOR 2019 5. Acasti Pharmaceuticals – current price Sultan-12/29/2018
566Health Canada Standard Processing License Provides Advantage for Cannabis ExtracSultan-12/27/2018
565Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in CanSultan-12/21/2018
564Top cannabis marketing and PR firm, Marigold Marketing & PR, to support NeptSultan-12/20/2018
563Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of Sultan-12/20/2018
562Cannabis Oils: 101 neptunecorp.comSultan-12/13/2018
561Presentation: LD Micro Main Event XI neptunecorp.comSultan-12/6/2018
560Tomorrow Neptune will present at @theLDMicro Main Event XI in Los Angeles at 9:0Sultan-12/5/2018
559Jim Hamilton, President & CEO, had the pleasure of meeting @jameswest on #miSultan-11/30/2018
558Acasti Pharma to Present at the 11th Annual LD Micro Main Event finance.yahoo.cSultan-11/29/2018
557Neptune to Participate in Fall 2018 Investor Conferences LAVAL, QC , Nov. 26, 2Sultan-11/26/2018
556Acasti Pharma's (ACST) CEO Jan D'Alvise on Q2 2018 Results - Earnings CaSultan-11/14/2018
555Signition LP Purchases New Holdings in Neptune Wellness Solutions Inc (NEPT) baSultan-11/14/2018
554Acasti Pharma has a potential blockbuster drug on its hands, Mackie Research saySultan-11/14/2018
553Neptune Wellness Solutions Inc. (NEPT) CEO Jim Hamilton on Q2 2019 Results - EarSultan-11/13/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):